MENU

LMAT Stock LeMaitre Vascular (LMAT, $86.39) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 2, 2026

A.I.dvisor
at Tickeron.com
Loading...
LMAT - LeMaitre Vascular
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $86.39
Daily change: +$1.42 (+1.67%)
Daily volume: 100.5K
Capitalization: $2B
Industry: Pharmaceuticals: Other

This is a Bullish indicator signaling LMAT's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 50 similar cases where LMAT's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

LMAT in upward trend: 10-day moving average moved above 50-day moving average on January 20, 2026

The 10-day moving average for LMAT crossed bullishly above the 50-day moving average on January 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LMAT's RSI Indicator exited the oversold zone, of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 03, 2026. You may want to consider a long position or call options on LMAT as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LMAT just turned positive on February 02, 2026. Looking at past instances where LMAT's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

LMAT moved above its 50-day moving average on January 30, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LMAT advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where LMAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for LMAT moved below the 200-day moving average on December 26, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LMAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LMAT broke above its upper Bollinger Band on January 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.238) is normal, around the industry mean (11.448). P/E Ratio (37.720) is within average values for comparable stocks, (149.436). Projected Growth (PEG Ratio) (1.894) is also within normal values, averaging (2.437). Dividend Yield (0.009) settles around the average of (0.017) among similar stocks. P/S Ratio (8.326) is also within normal values, averaging (111.001).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LMAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LMAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LMAT showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of vascular devices for vascular surgeons

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
63 Second Avenue
Phone
+1 781 221-2266
Employees
630
Web
https://www.lemaitre.com